Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06233513 · ClinicalTrials.gov registry record · NA
Vowel Space Expansion Sensorimotor Adaptation
A NA study of Speech, sponsored by University of Wisconsin, Madison.
- Recruiting
- Registry status
- NA
- Development phase
- 117
- Enrollment target
- 1
- Study location
NCT06233513: Recruiting NA study of Speech, sponsored by University of Wisconsin, Madison.
NCT06233513 is a NA study of Speech that is actively recruiting participants, run by University of Wisconsin, Madison. The registered enrollment target is 117 participants, below the 163-participant average among 9 other Speech trials with a reported enrollment target (28% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06233513, a NA study of Speech, is actively recruiting participants, sponsored by University of Wisconsin, Madison.
- RECRUITING
- Registry status
- NA
- Development phase
- 117 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study is to understand how the brain processes and controls speech in healthy people. The investigators are doing this research because it will help identify the mechanisms that allow people to perceive their own speech errors and to learn new speech sounds. 117 participants will be enrolled into this part of the study and can expect to be on study between 1 day (Experiment 1) and 4 weeks (Experiment 2).
Primary Outcome
AVS is a local measure of vowel spacing.
Conditions Studied
Interventions
- BEHAVIORAL Exp 3 Speaking Task
Study Locations (1)
Wisconsin
- University of Wisconsin - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 117 participants |
| Start Date | 2024-02-15 |
| Est. Completion | 2026-04 |
| Phase | NA |
What NCT06233513 shows while recruiting
NCT06233513 is an interventional study that assigns participants to a tested intervention. The registered 117 participants enrollment target is mid-sized for trials with a published cap, below the 163-participant average among 9 other Speech trials with a reported enrollment target (28% lower).
The record links to 1 condition, with Speech appearing as the primary indexed condition, and to 1 intervention - of which Exp 3 Speaking Task is the first listed.
NCT06233513 reports a single indexed study location in Wisconsin.
Frequently Asked Questions
What is clinical trial NCT06233513 about?
NCT06233513 is a clinical study titled "Vowel Space Expansion Sensorimotor Adaptation". The purpose of this research study is to understand how the brain processes and controls speech in healthy people. The investigators are doing this research because it will help identify the mechanisms that allow people to perceive their own speech errors and to learn new speech sounds. 117 particip...
What is the current status of trial NCT06233513?
This trial is currently recruiting. It is a NA study. The enrollment target is 117 participants. The study started on 2024-02-15. Estimated completion is 2026-04.
What conditions does trial NCT06233513 study?
This clinical trial studies the following conditions: Speech.
What interventions are being tested in trial NCT06233513?
The interventions under investigation include: Exp 3 Speaking Task (BEHAVIORAL).
Who is sponsoring clinical trial NCT06233513?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06233513 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Speech
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06233513's enrollment target sits among peer trials
117 6th of 9 higher than 4 of 9 other Speech trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Speech trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Speech Motor Learning and Retention (Aim 1)
RECRUITING · NA
-
Speech Motor Learning and Retention (Aim 2)
RECRUITING · NA
-
Effects of Clear Speech on Listening Effort and Memory in Sentence Processing
RECRUITING · NA
-
Talk With Me Baby to Enhance the Early Home Language Environment
RECRUITING · NA
-
Behavioral and Neural Characteristics of Adaptive Speech Motor Control
RECRUITING · NA
-
Social Influences on Sensorimotor Integration of Speech Production and Perception During Early Vocal Learning
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03539822 · 117 participants · Phase 1
Cabozantinib Plus Durvalumab With or Without Tremelimumab in Patients With Gastroesophageal Cancer and Other Gastrointestinal Malignancies
- NCT03786692 · 117 participants · Phase 2
Phase II Randomized Trial of Carboplatin+Pemetrexed+Bevacizumab+/- Atezolizumab in Stage IV NSCLC
- NCT04479696 · 117 participants · NA
Customized Neuro-Imaging Referenced Symptom Video for the Reduction of Patient and Caregiver Anxiety Around Radiation Treatment for Brain Tumors
- NCT04940585 · 117 participants · NA
ROSE in Sunset Park
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI